CGB - 1.9c to 7.2c - What will happen in the next 6 months., page-131

Sounds good but $3m is alot of money for CGB right now..We also wouldn't want to be in a rush to expand the share registry.

The tide might be turning but I'd be careful to take on too many initiatives just now.

Unless we see ground breaking revenue we are still likely to need atleast one more capital raise Christmas or in the new year.

Hopefully it's the last one at much higher sp to now.

I'm a huge supporter of the company but also a realist..Sure the short term announcement of purchasing AEB might be great for traders but what's it mean to long termers who have to pick up the bill?

Unless we got it for pennies no thanks.

IP is great too but how many years if ever before it translates to actual revenue?

I'll stick with T12...We have enough with Pharmocann, Canntab & BioHealth to make a fist of this without AEB.

See what happens.